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278Objective: Few studies have investigated the outcomes after surgical correction of severe isolated tricuspid
regurgitation.
Methods: The medical records of 51 consecutive patients (aged 55.8  12.9 years, 25 male) who underwent
tricuspid valve surgery at the Asan Medical Center between September 1996 and July 2010 were evaluated ret-
rospectively. All patients had severe isolated tricuspid regurgitation but no significant left-sided cardiac disease
or history of heart surgery.
Results: Tricuspid valve repair (n ¼ 37, 72.5%) or replacement (n ¼ 14, 27.5%) was performed. Replacement
involvedmechanical (n¼ 4) or bioprosthetic valves (n¼ 10). One early death occurred (2.0%). During amedian
follow-up period of 47.4 months (interquartile range, 10.4-61.4 months), 9 late deaths, 3 readmissions for con-
gestive heart failure, 2 heart transplantations, and 1 tricuspid valve reoperation occurred. Overall and event-free
survivals at 5 years were 83.5%  5.4% and 77.3%  6.1%, respectively. In the multivariable Cox regression
analysis, preoperative hemoglobin (P ¼ .045), serum bilirubin (P ¼ .008), estimated glomerular filtration rate
(P¼ .045), and systolic right ventricular dimension (P¼ .047) were significant and independent determinants of
clinical outcome. On serial echocardiographic evaluations (median follow-up period, 28.5 months; interquartile
range, 18.9-68.7 months), moderate-to-severe tricuspid regurgitation was detected in 21 patients (41%). Severe
tricuspid regurgitation after tricuspid valve repair or bioprosthetic valve replacement was a significant predictor
of poor event-free survival, even after adjustment for preoperative risk factors (P ¼ .036).
Conclusions: In the present cohort, preoperative anemia, renal/hepatic dysfunction, right ventricular dilatation,
and significant postoperative tricuspid regurgitation were associated with poor outcomes. Timely surgery is ad-
visable in patients with severe isolated tricuspid regurgitation before the development of anemia, organ dysfunc-
tion, or right ventricular dilatation. (J Thorac Cardiovasc Surg 2013;146:278-84)Although severe tricuspid regurgitation (TR) is associated
with a poor prognosis,1 current guidelines do not suffi-
ciently specify the optimal timing for surgery in patients
with severe isolated TR.2,3 This is partly attributable to
a lack of appropriate data because there is a relative
paucity of patients with isolated TR compared with
patients with left-sided valvular heart disease. To date,
few studies have investigated the clinical outcomes after
isolated tricuspid valve (TV) surgery.4-6
Isolated TV surgery has been associated with a high rate
of mortality, and the long-term outcomes are poor. Clini-
cians therefore tend to delay surgery until medical treatment
fails to alleviate the symptoms of advanced heart failure.7-10e Department of Thoracic and Cardiovascular Surgery, Asan Medical Center,
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The Journal of Thoracic and Cardiovascular SurgConsequently, patients who are referred for surgery are
typically medically compromised and at high risk, which
may explain the poor surgical outcomes.11 Further research
to evaluate the surgical outcomes and prognostic factors in
this unique population is therefore warranted to establish
the optimal timing for surgery and thereby improve surgical
outcomes. The present study evaluates the long-term out-
comes in patients undergoing first-time TV surgery for se-
vere isolated TR and identifies prognostic indicators.MATERIALS AND METHODS
Patients
Between September 1996 and July 2010, a total of 486 patients under-
went TV surgery for severe TR at the AsanMedical Center in Seoul, Korea.
Patients who underwent concomitant left-sided valve surgery (n ¼ 359),
coronary artery bypass (n ¼ 15), or correction of a congenital heart defect
(n¼ 20) were excluded from the present analyses. Patients with the Ebstein
anomaly (n¼ 1), active endocarditis (n¼ 5), or a history of cardiac surgery
(n ¼ 35) were also excluded. This resulted in a sample of 51 consecutive
patients who had undergone first-time isolated TV surgery for severe TR.
Surgery was determined at the attending physician’s discretion by taking
into consideration age, symptoms, and other comorbidities of the patients.
The study was approved by the institutional ethics committee/review board
of the Asan Medical Center, and the requirement for informed patient
consent was waived in view of the retrospective nature of the study.ery c August 2013
Abbreviations and Acronyms
CHF ¼ congestive heart failure
RV ¼ right ventricle
TR ¼ tricuspid regurgitation
TV ¼ tricuspid valve
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DEchocardiography
Two-dimensional echocardiography and Doppler color-flow imaging
were performed using a Hewlett-Packard Sonos 2500 or a 5500 imaging
system equipped with a 2.5 MHz transducer (Hewlett-Packard, Andover,
Mass). Echocardiography was performed in all patients within the
2-month preoperative period. The degree of TR was evaluated using the
apical 4-chamber view. Mild, moderate, and severe TR were defined by
a distal jet area of less than 5 cm2, 5 to 10 cm2, and more than 10 cm2, re-
spectively.12 Right ventricle (RV) end-diastolic and end-systolic dimen-
sions were measured in the RVoutflow tract from the parasternal view.
Surgical Procedures
Surgery involved a median sternotomy (n ¼ 41) or a port-access right
minithoracotomy (n ¼ 10), depending on the preference of the surgeon.
The sternotomy approach involved conventional ascending aorta and bi-
caval cannulation. The minimally invasive approach involved peripheral
cannulation through the right internal jugular vein, right femoral vein,
and right femoral artery. TV surgery was performed under beating heart
(n ¼ 11) or cardioplegic arrest (n ¼ 40) conditions. TV repair (n ¼ 37)
or replacement (n ¼ 14) was performed. In cases of TV replacement, leaf-
lets and subvalvular structures were preserved. The decision on whether to
perform TV repair or replacement was influenced by the preoperative clin-
ical status and echocardiographic parameters of each individual patient.
However, the final decision was made at the discretion of the attending
surgeon.
Follow-up
Follow-up data were obtained until the end of August 2011 through 3- to
6-month interval visits to the outpatient clinic. For those who were fol-
lowed up at other hospitals (n ¼ 9), clinical information was obtained
from telephone contacts. Data on vital status, dates of death, and causes
of death were confirmed by accessing the Korean National Registry of Vital
Statistics. All deaths were considered to have been of cardiac origin unless
a noncardiac origin had been established clinically or determined at au-
topsy. Early mortality was defined as the occurrence of death within 30
days of surgery.
The primary outcomes of interest were all-cause death, requirement for
TV reoperation or heart transplantation, and readmission due to congestive
heart failure (CHF). For the purposes of the present study, CHFwas defined
as the presence of resting dyspnea and a requirement for intravenous di-
uretic therapy.
Statistics
Categoric variables are presented as frequencies and percentages, and
were compared using Fisher exact tests. Continuous variables are ex-
pressed as the mean  standard deviation or the median and the range,
and were compared using the Mann–WhitneyU test. Kaplan–Meier curves
were used to delineate the survival or freedom from major adverse events.
Log-rank tests were used to compare between-group differences in these
rates. For the multivariate analyses, Cox proportional hazard models
were used to determine the risk factors for mortality and adverse events.
Baseline variables listed in Tables 1 and 2 were evaluated in a univariate
model. Variables with a P value of .20 or less in univariate analyses wereThe Journal of Thoracic and Caconsidered candidates for the multivariable Cox models. The multivariate
analyses involved a backward elimination technique, and only variables
with a P value less than .10 were used in the final model. The Statistical
Package for the Social Sciences version 14.0 (SPSS Inc, Chicago, Ill)
was used for the statistical analyses.RESULTS
Baseline Characteristics
The mean age at surgery was 55.8  12.9 years, and 25
patients (49.0%) were male. Sixteen patients (31.4%) had
functional class III or IV heart failure according to the New
York Heart Association classification, and 3 patients (5.9%)
had liver cirrhosis. Eight patients (15.7%) had a history of
blunt chest trauma. Twenty-seven patients (52.9%) had iso-
lated annular dilatation with (n ¼ 20) or without (n ¼ 7)
leaflet tethering, and 21 patients (41.2%) had leaflet pro-
lapse. Leaflet thickening was observed in 4 patients. Base-
line demographic, laboratory, and echocardiographic
profiles are summarized in Tables 1 and 2. Patients who un-
derwent TV replacement were more likely to have advanced
heart failure symptoms, more severe TR, and larger systolic
and diastolic RV dimensions, and were less likely to un-
dergo a concomitant Maze procedure in the presence of
atrial fibrillation than patients who underwent TV repair.
Of the 37 patients who underwent TV repair, 34 under-
went ring annuloplasty and 1 underwent DeVega annulo-
plasty. In 22 of these patients, TV repair was combined
with a total of 24 TV leaflet procedures. These procedures
were new chordae formation (n ¼ 9), commissuroplasty
(n ¼ 6), leaflet extension (n ¼ 4), the Alfieri technique
(n ¼ 4), and papillary muscle reattachment (n ¼ 1). For
ring annuloplasty, rigid (n ¼ 12) or flexible (n ¼ 18) rings,
or annuloplasty bands (n¼ 4) were used. For the 14 patients
who underwent TV replacement, mechanical (n¼ 4) or bio-
prosthetic (n ¼ 10; pericardial valves in 8 and porcine
valves in 2) valves were implanted.Early Surgical Outcomes
The mean aortic clamping and cardiopulmonary bypass
times were 57.7  26.2 minutes and 100.8  41.0 minutes,
respectively. No significant differences in these durations
were observed between the TV repair and replacement
groups (P ¼ .48 and .23, respectively).
One early death (2.0%) occurred on the second postoper-
ative day in a patientwhohadundergone bioprostheticTV re-
placement. This was caused by severe RV dysfunction. Table
3 summarizes the early postoperative outcomes. No signifi-
cant differences in early postoperative complications were
observed between the TV repair and replacement groups.Late Outcomes
Follow-up was complete (100%) with a median
follow-up period of 47.4 months (interquartile range,
10.4-61.4 months). During this period, 8 late deathsrdiovascular Surgery c Volume 146, Number 2 279
TABLE 1. Baseline demographic and laboratory characteristics of the
study cohort
Repair Replacement
P
value
No. of patients 37 14
Age, y 55.7  13.8 56.1  10.7 .92
Male gender, n (%) 19 (51.4) 6 (42.9) .76
Diabetes mellitus, n (%) 6 (16.2) 2 (14.3) >.99
Hypertension, n (%) 10 (27.0) 3 (21.4) >.99
Atrial fibrillation, n (%) 20 (54.0) 6 (42.9) .54
Maze procedure, n (%) 9 (24.3) 0 .049*
History of stroke, n (%) 1 (2.7) 0 >.99
Liver cirrhosis, n (%) 3 (8.1) 0 .27
Chronic lung disease, n (%) 1 (2.7) 1 (7.1) .47
NYHA functional class, n (%) .029*
I 9 (24.3) 0
II 20 (54.0) 6 (42.9)
III 5 (13.5) 3 (21.4)
IV 3 (8.1) 5 (35.7)
History of blunt chest trauma,
n (%)
4 (10.8) 4 (28.6) .12
Hemoglobin, g/dL 13.0  2.3 12.3  2.0 .31
Platelet count, 31000/mL 176.8  68.2 179.2  80.2 .91
Albumin, g/dL 3.9  0.5 3.8  0.5 .50
Creatinine, mg/dL 1.1  0.6 0.8  0.2 .13
eGFR, mL/min/1.73 m2 74.7  35.3 84.2  12.7 .33
Bilirubin, mg/dL 1.2  0.5 1.2  0.7 .79
B-type natriuretic peptide,
pg/mL
259.2  293.2 561.7  391 .31
C-reactive protein, g/dL 0.3  0.6 1.3  1.5 .090
NYHA, New York Heart Association; eGFR, estimated glomerular filtration rate.
*P<.05.
TABLE 2. Baseline echocardiographic data of the study cohort
Repair
(n ¼ 37)
Replacement
(n ¼ 14)
P
value
Echocardiographic data
TR jet area, cm2 21.6  5.8 36.6  18.1 .050*
TV annular dilatation, n (%) 30 (81.1) 13 (92.9) .30
TV tethering, n (%) 17 (45.9) 7 (50.0) >.99
Leaflet abnormality, n (%) 17 (45.9) 7 (50.0) >.99
Prolapse 15 (40.5) 5 (35.7) .75
Thickening 1 (2.7) 2 (14.3) .12
Thickeningþprolapse 1 (2.7) 0 >.99
RVIDs, mm 31.2  4.1 37.9  6.0 .002*
RVIDd, mm 38.7  5.8 43.2  7.5 .053
RV dysfunction, n (%) 13 (35.1) 7 (50.0) .36
RV dilatation, n (%) 31 (83.8) 13 (92.9) .66
IVC plethora, n (%) 20 (54.1) 12 (85.7) .053
Hepatic vein reversal flow, n (%) 27 (73.0) 12 (85.7) .34
LV ejection fraction,% 57.8  7.9 59.6  6.9 .45
LVIDs, mm 31.1  6.9 28.6  5.9 .24
LVIDd, mm 46.6  6.4 42.8  7.0 .070
TR PG (peak), mm Hg 27.5  9.0 22.6  7.7 .095
TR, Tricuspid regurgitation; TV, tricuspid valve; RVIDs, right ventricular end-systolic
dimension; RVIDd, right ventricular end-diastolic dimension; RV, right ventricle;
IVC, inferior vena cava; LV, left ventricle; LVIDs, left ventricular end-systolic dimen-
sion; LVIDd, left ventricular end-diastolic dimension; PG, pressure gradient. *P<.05.
TABLE 3. Early postoperative outcomes in the study cohort
Variables, n (%)
Total
(n ¼ 51)
Repair
(n ¼ 37)
Replacement
(n ¼ 14)
P
value
Early or in-hospital mortality 1 (2.0) 0 1 (7.1) .10
No. of patients with major
complications
10 (19.6) 6 (16.2) 4 (28.6) .32
Bleeding reexploration 5 (9.8) 3 (8.1) 2 (14.3) .61
Acute renal failure 3 (5.9) 2 (5.4) 1 (7.1) >.99
Low cardiac output
syndrome
5 (9.8) 4 (10.8) 1 (7.1) .69
Wound infection 1 (2.0) 1 (2.7) 0 >.99
Pulmonary infection 1 (2.0) 1 (2.7) 0 >.99
Permanent pacer
implantation
2 (3.9) 2 (5.4) 0 >.99
Ventricular tachycardia 1 (2.0) 1 (2.7) 0 >.99
Sepsis, multiorgan failure 1 (2.0) 1 (2.7) 0 >.99
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D(4 cardiac, 3 unknown, and 1 malignancy), 4 readmissions
due to CHF, and 2 heart transplantations occurred. One
patient from the TV repair group underwent TV replace-
ment for severe TR 1 year after initial surgery. The overall
survival at 5 years was 83.5%  5.4%. Survival free of
CHF, heart transplantation, or TV reoperation was
77.3%  6.1% at 5 years. Figure 1 depicts overall survival
and event-free survival according to surgery type. No sig-
nificant differences in survival or event-free survival were
observed between the TV repair and replacement groups
(P ¼ .22 and .59, respectively).
Multivariate Cox regression analysis showed that the pre-
operative levels of hemoglobin, estimated glomerular filtra-
tion rate, and bilirubin, and RVend-systolic dimension were
significant and independent determinants of the composite
adverse outcome (death, CHF, heart transplantation, and
TV reoperation) (Table 4).
At the end of follow-up, 42 patients were alive. Of them,
New York Heart Association functional class could be as-
sessed in 40 patients. In 2 patients, functional class could
not be assessed because of multiple injuries (traffic acci-
dent) and cancer chemotherapy requiring hospitalization.
Figure 2 shows comparisons of preoperative and last280 The Journal of Thoracic and Cardiovascular Surgfollow-up New York Heart Association functional class.
Patients showed significant improvements in functional
classes at the end of follow-up (P<.001) compared with
their preoperative status.Postoperative Tricuspid Valve Function
Of the 6-month survivors (n ¼ 47), 37 patients (78.7%)
underwent late (>6 months) postoperative echocardio-
graphic evaluation. The median duration of echocardio-
graphic follow-up was 28.5 months (interquartile range,
18.9-68.7 months). The preoperative and final follow-up
echocardiographic parameters are summarized in Table 5.
At the final follow-up, systolic and diastolic RVery c August 2013
FIGURE 1. Survival (A) and event-free survival (B) curves. The survival at 5 years was 79.8%  6.9% in the repair group and 92.9%  6.9% in the
replacement group. Major events were defined as tricuspid reoperation, heart transplantation, and readmission due to CHF.
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Ddimensions, TR jet area, and TR degree were significantly
reduced compared with the values obtained at the preoper-
ative assessment. During the serial follow-up echocardio-
graphic evaluations, moderate-to-severe TV dysfunction
developed in 21 patients at least once (moderate, n ¼ 15;
severe, n ¼ 6). Figure 3 shows freedom from TR according
to the TR degree and type of TV surgery. No significant
difference in TR-free rate was observed between the TV
repair and replacement groups. However, in the TV re-
placement group, TR recurrence occurred only in patients
with a bioprosthetic implant (n ¼ 4). Of 4 bioprosthetic
valve dysfunctions, 3 were from pericardial valves and 1
was from a porcine valve. In the group of patients who un-
derwent ring annuloplasty (n ¼ 34), there were no signifi-
cant differences in freedom from moderate-to-severe TR
(P ¼ .64) or freedom from severe TR (P ¼ .51) among
the use of rigid rings, flexible rings, and annuloplasty
bands. Severe postoperative TR was significantly associ-
ated with major adverse outcomes, as shown in Figure 4
(P ¼ .036).TABLE 4. Multivariate Cox-regression analysis for event-free
survival
Hazard
ratio
95% Confidence
interval
P
value
Hemoglobin (by 1 g/dL increment) 0.77 0.60-0.99 .045
eGFR (by 10 mL/min/1.73 m2
increment)
0.67 0.45-0.99 .045
Bilirubin (by 0.1 mg/dL increment) 6.26 1.63-24.1 .008
RVIDs (by 1-mm increment) 1.17 1.01-1.36 .047
eGFR, Estimated glomerular filtration rate; RVIDs, right ventricular end-systolic
dimension.
The Journal of Thoracic and CaDISCUSSION
In addition to the relative paucity of patients with primary
isolated TR compared with patients with left-sided valvular
heart disease, there are 2 main reasons why isolated TV
surgery is uncommon in clinical practice. First, the risk of
mortality with isolated TV surgery is reported to be high,
sometimes unacceptably so, and thus clinicians tend to hes-
itate in referring for surgical intervention. Second, unlike
left-sided valvular heart disease, isolated TR can be toler-
ated relatively well and over a long period of time, even
when severe.FIGURE 2. New York Heart Association functional class before surgery
and at last-follow-up. *P<.001 by marginal homogeneity test. yA patient
who had tuberculous destroyed lung before surgery. NYHA, New York
Heart Association.
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TABLE 5. Comparison of preoperative and final follow-up
(>6 months postoperatively) echocardiographic evaluation
Preoperative
(n ¼ 51)
Final follow-up>6 mo
(n ¼ 37)
P
value
LV ejection fraction,% 58.2  7.6 57.9  9.4 .77
RVIDs, mm 32.7  5.3 28.4  9.8 .034*
RVIDd, mm 40.0  6.5 35.5  9.3 .044*
RV dilatation, n (%) 44 (86.3) 16 (43.2) <.001*
RV dysfunction, n (%) 20 (39.2) 9 (24.3) .21
TR PG (peak), mm Hg 26.3  8.9 28.1  13.0 .21
TR jet area, cm2 24.5  11.0 5.9  5.3 <.001*
TR grade <.001*
None to trace 0 10 (27.0)
Mild 0 13 (35.1)
Moderate 0 10 (27.0)
Severe 51 (100.0) 4 (10.8)
Wilcoxon-signed rank test was used for continuous variables, and McNemar or mar-
ginal homogeneity tests were used for categoric variables. LV, Left ventricle; RVIDs,
right ventricular end-systolic dimension; RVIDd, right ventricular end-diastolic di-
mension; RV, right ventricle; TR, tricuspid regurgitation; PG, pressure gradient.
*P<.05.
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Association guidelines suggest that TV replacement or an-
nuloplasty is reasonable for severe primaryTRwhen ‘‘symp-
tomatic’’ (class IIa recommendation and level of evidence
C).3 However, early symptoms are vague, and overt symp-
toms usually become manifest only when advanced right-
sided heart failure develops. Thus, symptom-guided surgical
indications may render surgical outcomes even poorer.4
Operative mortality of up to 36% has been reported for
primary TR surgery, and this renders surgeons wary of opt-
ing for surgical intervention.7,9,10 Long-term outcomes are
also reported to be poor, for instance, Iscan and colleagues8
found that the 10-year survival after TV replacement for pa-
tients aged 33  15 years was less than 40%.FIGURE 3. Freedom from moderate-to-severe TR curves. A, Separate curves
severe TR (dotted line). B, Freedom from moderate-to-severe TR curves, acco
282 The Journal of Thoracic and Cardiovascular SurgAccording to several recent reports, clinical outcomes
after isolated TV surgery are mainly influenced by preoper-
ative clinical parameters; thus, overall long-term outcomes
may be improved by appropriate patient selection and early
surgical referral.4,6,13 Topilsky and colleagues6 performed
a retrospective analysis of the data of 189 patients who un-
derwent TV replacement for severe TR. Operative mortality
was 10%, and the 5-year survival was 55.9%. The authors
found that long-term survival was affected by preoperative
parameters, such as advanced heart failure symptoms,
Charlson comorbidity index, RV function, and serum creat-
inine level; therefore, they concluded that TV replacement
can be performed with acceptable early and long-term out-
comes if patients undergo surgery before the onset of right-
sided heart failure or end-organ damage.
Lee and colleagues14 used propensity score matching to
compare the rate of long-term mortality between patients
undergoing surgical or medical treatment for isolated TR
and found that the survival was superior in the surgery
group. This finding indicates that TV surgery is not such
a high-risk procedure as traditionally believed and that early
surgical intervention can improve survival in patients with
severe isolated TR.
A recent report by Kim and colleagues4 is one of the larg-
est series of isolated TV surgery patients reported to date.
They showed that preoperative hemoglobin level and RV
end-systolic area were independent determinants of event-
free survival after isolated TV surgery in 61 consecutive
patients. However, their report contains heterogeneous pop-
ulations with primary and secondary TR, because it in-
cludes patients who had undergone previous left-sided
heart valve surgery (n ¼ 57). The pathophysiology of TR
development in such patients is likely to differ from that
of patients with no history of heart surgery because leftfor freedom from severe TR (solid line) and freedom from moderate-to-
rding to surgery type (repair vs replacement). TR, Tricuspid regurgitation.
ery c August 2013
FIGURE 4. Event-free survival curves according to the presence of severe
postoperative TR. TR, Tricuspid regurgitation.
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hypertension may be implicated in most cases. These 2 pop-
ulations (primary vs secondary TR) may have a completely
different long-term prognosis.
The present study revealed that significant postoperative
TR, which was seen in patients who had undergone TV re-
pair, was associated with poor clinical outcomes. Although
the TV leaflet morphology and degree of tethering were
considered suitable for repair, and TV function seemed sat-
isfactory immediately after TV repair, late postoperative
moderate-to-severe TR developed in a significant propor-
tion of patients. The recurrence of TR was time-related
through long-term follow-up (Figure 3). The present find-
ings suggest that patients with a higher risk of postoperative
TR may benefit from TV replacement with a mechanical
prosthesis. This hypothesis is supported by the results of
a recent study by Moraca and colleagues,15 in which pro-
pensity score matching showed that TV replacement re-
sulted in survival and event-free survival similar to those
for TV repair. Their results imply that TV replacement
should be considered in patients with a reasonable risk of re-
gurgitation recurrence after repair.
In the present cohort, echocardiographic assessments re-
vealed that the durability of bioprosthetic valves was less
than expected. Severe postoperative TR at 19.3 to 50.7
months after surgery developed in 4 of 10 patients with bio-
prosthetic valves. In 2 of these patients, moderate tricuspid
stenosis was also observed. All 4 patients had leaflet motion
limitation with noncalcified thickening. One of the 4 pa-
tients underwent heart transplantation 30.9 months postop-
eratively for severe RV failure, and subsequent examination
of the explanted TV prosthesis by a pathologist confirmed
degenerative thickening of valve leaflets. By contrast,
Dalrymple-Hay and colleagues16 reported excellent dura-
bility of bioprosthetic valves. Freedom from TV reoperationThe Journal of Thoracic and Cain their cohort was 71.0%  2.8% at 15 years, which was
similar to that observed for mechanical valve replacement.
A meta-analysis of 11 published studies comparing surgical
outcomes between bioprosthesis and mechanical valves for
TV replacement revealed that the differences in reoperation
rates or survival were trivial and insignificant up to year
10.17 However, a low reoperation rate cannot be considered
an entirely satisfactory surrogate for excellent durability. In
particular, given that candidates for TV reoperation are
likely to experience an exacerbation of preexisting RV dys-
function and that the operative risk may thus be unaccept-
ably high, the decision as to whether to perform TV
reoperation is challenging. In this situation, patients with
significant postoperative TR are more likely to receive con-
servative medical treatment to control their heart failure
than to undergo TV reoperation. Few studies have evaluated
the durability of bioprosthetic valves in TV surgery on the
basis of echocardiographic evaluations performed long af-
ter surgery. In the present study, only 1 of the 4 patients
with significant postoperative TR after bioprosthetic valve
implantation underwent cardiac reoperation for TR (heart
transplantation). This finding supports the hypothesis that
TV reoperation cannot be a complete surrogate for TV dys-
function after surgery.
The present study showed that the presence of renal or he-
patic dysfunction, evidenced by a high bilirubin level and de-
creased estimated glomerular filtration rate, was associated
with poor clinical outcomes. In the same context, Ailawadi
and colleagues18 suggested a more comprehensive model
for organ dysfunction to predict mortality after TV surgery.
The Model for End-Stage Liver Disease score, which is cal-
culated from baseline bilirubin, international normalized ra-
tio, and creatinine, was used in their study including 168
patients undergoing TV surgery. Because the Model for
End-Stage Liver Disease score accurately predicted mortal-
ity, the authors concluded that the model can offer a simple
and effective method of risk stratification in these patients.
Study Limitations
The present study has several limitations. First, the study
was retrospective and observational, and therefore had lim-
itations inherent to this type of study design. Second, the
sample size was small, and thus no robust conclusions can
be drawn, although our sample size was relatively large
compared with previous studies. Third, sophisticated vari-
ables, such as the tricuspid annular dimension, degree of
TV tethering, and quantitative parameters of RV function,
could not be estimated.
CONCLUSIONS
Long-term clinical outcomes after surgical correction for
severe isolated TR were mainly determined by preoperative
factors, such as anemia, renal/hepatic dysfunction, and de-
gree of RV dilatation. These outcomes were not influencedrdiovascular Surgery c Volume 146, Number 2 283
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Dby the type of surgery. The present findings suggest that
timely surgery is indicated before the development of ane-
mia or organ dysfunctions, and that the TV procedure can be
selected according to the clinical status of the individual pa-
tient and at the discretion of the attending surgeon.References
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